TY  - GEN
AU  - Martínez-Pina, Verónica
AU  - Bayés-Genís, Antoni
AU  - Nuñez, Julio
AU  - Riquelme-Pérez, Alejandro
AU  - Cebreiros-López, Iria
AU  - Morillas, Herminio
AU  - Cobo-Marcos, Marta
AU  - García-Pinilla, José M
AU  - Rodríguez-Palomares, Juan F
AU  - Dobarro, David
AU  - Restrepo-Córdoba, María A
AU  - González-Juanatey, José R
AU  - Zamorano, José L
AU  - Noguera-Velasco, José A
AU  - Pascual-Figal, Domingo A
PY  - 2025
UR  - https://hdl.handle.net/20.500.12105/27439
AB  - Dapagliflozin improves clinical outcomes in patients with chronic heart failure (HF), irrespective of left ventricular ejection fraction. However, its effects on circulating biomarkers that reflect distinct pathophysiological pathways remain...
LA  - eng
PB  - EDICIONES DOYMA SA
KW  - Biomarcadores
KW  - Biomarkers
KW  - Dapagliflozin
KW  - Dapagliflozina
KW  - Heart failure
KW  - Insuficiencia cardiaca
TI  - Impact of dapagliflozin on key pathophysiological pathways underlying chronic heart failure progression: the DAPA-MODA biomarker study.
TY  - research article
ER  -